Hepatitis B Surface Antigen (HBsAg)
HBsAg is the first detectable marker of hepatitis B infection. A positive result indicates active hepatitis B, either acute or chronic. This test is essential for screening and public health.
- Free home collection
- Physician-reviewed report
24 Hours
Turnaround
Blood
Sample
What the Hepatitis B Surface Antigen (HBsAg) test tells you
The hepatitis B surface antigen is a protein from the outer coat of the hepatitis B virus. Finding it in blood means the virus itself is present in your body now: this is a marker of current infection, not a record of something your immune system met in the past and not a consequence of having been vaccinated. It is usually the first hepatitis B marker to become detectable after infection, often appearing before any symptoms do, which is why it is the standard screening test.
This point causes more confusion than almost any other in liver testing, so it is worth setting out plainly. Three different results are all loosely called "a hepatitis B test". The surface antigen means the virus is present now. The surface antibody means you are protected, either because a vaccine taught your immune system to make it or because you cleared an infection in the past. The core antibody means your body has encountered the actual virus at some point, whatever happened afterwards. A vaccine produces the antibody and can never make you antigen-positive in the long run, so a vaccinated person's surface antigen test is negative.
A positive surface antigen result is a reason to see a doctor promptly, not a conclusion in itself. It is normally repeated for confirmation and then followed by further tests that answer the questions this one cannot: whether the infection is recent or long-standing, whether the virus is actively multiplying, and how the liver is coping. Antigen that is still present many months later indicates a long-standing infection. That is worth knowing without being frightening: hepatitis B is usually managed rather than cured, but it is very manageable, and with regular monitoring and effective long-term treatment when it is needed, most people keep the virus under control and their liver healthy.
Routine screening for hepatitis B infection, pre-vaccination testing, pregnancy screening, and evaluation of acute hepatitis symptoms.
- Detects current infection
A positive result means hepatitis B virus is present in the body now, rather than simply having been encountered at some point in the past.
- The standard screening marker
It is usually the first marker to appear after infection, often before any symptoms, which makes it the front-line test.
- Protects mother and baby
Screening in pregnancy allows steps to be arranged around delivery that greatly reduce the chance of the baby being affected.
- Opens the right next steps
A positive result directs your doctor towards the further tests that establish how active the infection is and how the liver is doing.
Reasons your doctor may request the Hepatitis B Surface Antigen (HBsAg) test
Your doctor may order this test for any of the reasons below. Some are routine checks, others follow specific symptoms or an earlier result.
Routine & pre-vaccination screening
- Routine screening for hepatitis B, including before starting a vaccination course.
- Pre-employment or fitness-to-work health screening where it is required.
Jaundice & abnormal liver tests
- Investigation of jaundice, unexplained fatigue or abnormal liver blood tests.
Pregnancy, treatment & exposure
- Antenatal screening as part of standard pregnancy care.
- Assessment before chemotherapy, biologic therapy or other immune-suppressing treatment.
- Assessment after a possible exposure, such as a needlestick injury at work.
This test looks for a protein on the surface of the hepatitis B virus, and is reported as "Non-Reactive / Negative" or "Reactive / Positive". A "Reactive / Positive" result indicates current infection, not past exposure, and not vaccination. It may be recent, long-standing, or inactive carriage where the antigen is present while liver tests and viral activity are quiet; it can also follow reactivation during chemotherapy or immune-suppressing treatment. Detection shortly after a hepatitis B vaccine dose reflects vaccine antigen and settles quickly. A "Non-Reactive / Negative" result does not cover very early infection before the antigen has appeared. The test gives no measure of viral activity or liver damage, and does not show whether you are immune: a different marker measures that. Your doctor confirms a positive result and interprets it with further markers and your history.
Hepatitis B Surface Antigen (HBsAg)
This test looks for a protein on the surface of the hepatitis B virus, and is reported as "Non-Reactive / Negative" or "Reactive / Positive". A "Reactive / Positive" result indicates current infection, not past exposure, and not vaccination. It may be recent, long-standing, or inactive carriage where the antigen is present while liver tests and viral activity are quiet; it can also follow reactivation during chemotherapy or immune-suppressing treatment. Detection shortly after a hepatitis B vaccine dose reflects vaccine antigen and settles quickly. A "Non-Reactive / Negative" result does not cover very early infection before the antigen has appeared. The test gives no measure of viral activity or liver damage, and does not show whether you are immune: a different marker measures that. Your doctor confirms a positive result and interprets it with further markers and your history.
No infection or antibodies detected: a negative result.
Detected: a positive result. Please consult your physician for confirmation and next steps.
This test is reported descriptively rather than on a numeric scale: each finding below explains what your report may say.
This information is for general education only and is not medical advice. Reference ranges can vary by laboratory, age, sex, and individual factors. Always consult your physician or doctor to interpret your results.
What a higher result can point to
- Recent hepatitis B infection, in which the antigen appears early and often before symptoms.
- Long-standing hepatitis B infection, where the antigen has remained detectable over many months.
- Inactive carriage of the virus, where the antigen is present but liver tests and viral activity are quiet.
- Reactivation of hepatitis B in someone receiving chemotherapy or immune-suppressing medicines.
- Transient detection shortly after a dose of hepatitis B vaccine, which reflects vaccine antigen and settles quickly.
These are possibilities, not diagnoses. A single value outside the reference range is interpreted alongside your symptoms, history and other tests: your doctor decides what it means for you.
What this test cannot tell you
- A positive result alone cannot say whether the infection is recent or long-standing, which needs additional markers.
- It gives no information about how much virus is present or how the liver has been affected.
- A negative result does not exclude very early infection before the antigen has appeared, or the uncommon situation where virus is present without detectable antigen.
- This test does not show whether you are immune to hepatitis B; protection is measured by a different marker.
Risks of the blood draw
- Mild bruising or brief soreness where the needle went in.
- Occasional lightheadedness, which settles after a few minutes of rest.
- Bleeding or infection at the site, which is rare with sterile single-use equipment.
- 1A positive result indicates current hepatitis B infection, not past exposure and not vaccination.
- 2Vaccination produces the protective antibody and does not make this test positive in the long run.
- 3A positive result is confirmed and followed by further tests before any conclusion is drawn.
- 4Antigen still present after many months points to a long-standing rather than a recent infection.
- 5Hepatitis B is usually managed rather than cured, and with monitoring and treatment when needed most people do well.
- STI & STDHBV PCR Qualitative
HBV PCR detects hepatitis B virus DNA in the blood, confirming active viral replication. It is more sensitive than antigen/antibody tests and…
910View - BiochemistryLiver Function Test (LFT)
LFT is a comprehensive panel that evaluates liver health by measuring enzymes (ALT, AST, ALP, GGT), bilirubin, albumin, and total protein. It helps…
210View - STI & STDHepatitis C Antibody (Anti-HCV)
This test detects antibodies to the hepatitis C virus. A positive result means you have been exposed to HCV, but does not distinguish past from…
170View - BiochemistryAlanine Aminotransferase (ALT/SGPT)
ALT is a liver enzyme that is released into the blood when liver cells are damaged. This test helps detect liver inflammation or injury from…
120View
Frequently Asked Questions
Everything you need to know about the Hepatitis B Surface Antigen (HBsAg) test. Can't find what you're looking for?
Talk to our team→The vaccine teaches your immune system to make the protective surface antibody; it does not put the virus in your body, so it will not make you antigen-positive in any lasting way. Antigen from a dose given within the last few days can occasionally be detected briefly, which settles on its own. The test is still done because vaccination is not always complete or effective, and because screening looks for infection acquired before vaccination.
Not on its own. The surface antigen shows the virus is present now, but a single result cannot distinguish a recent infection from one that has been there for a long time. Infection is considered long-standing when the antigen is still detectable many months later. Your doctor arranges repeat and additional testing to establish which situation applies to you.
The antigen is part of the virus, so finding it means the virus is present. The antibody is made by your immune system, so finding it means you are protected: either through vaccination or after clearing an infection. They answer opposite questions, which is why laboratories test for both and why one result should never be read as though it were the other.
See a doctor promptly, and bring the report. The result will normally be repeated for confirmation, and further tests will look at whether the virus is actively multiplying and how your liver is doing. From there, some people need treatment and some are simply monitored. This is a manageable condition with good long-term outcomes for most people, and it should not be interpreted or acted on alone.
HBsAg is the first detectable marker of hepatitis B infection. A positive result indicates active hepatitis B, either acute or chronic. This test is essential for screening and public health.
Routine screening for hepatitis B infection, pre-vaccination testing, pregnancy screening, and evaluation of acute hepatitis symptoms.
No, fasting is not required for the Active Hepatitis B Marker test, so you can eat and drink normally beforehand.
The Active Hepatitis B Marker test uses a blood sample, collected quickly by our DHA-licensed phlebotomist with minimal discomfort.
Results for the Active Hepatitis B Marker test are typically ready within 24 hours. You will receive a secure digital report, and your Smart Report highlights anything outside the normal range.
The Active Hepatitis B Marker test is AED 170, which includes free home sample collection and a physician-reviewed report. You can also build a custom panel and pay only for the markers you choose.
Yes. A DHA-licensed phlebotomist can collect your sample at home or the office anywhere in Dubai at no extra cost, 7 days a week. See how it works.
It is commonly chosen by sexually active adults. If you are not sure it is right for you, our care team is happy to advise.
Add the Active Hepatitis B Marker test to your cart and complete the short booking wizard, choosing home collection or a lab visit. Guest checkout lets you book without creating an account.
Yes. It is processed at our EIAC-accredited laboratory (ISO 15189:2022) under DHA license 0046381 and verified by board-certified pathologists.
Every report includes reference ranges and plain-language notes. If you have questions, our care team can arrange a clinician review: just get in touch.
Absolutely. Add it to a curated health package or bundle it with any of our 160+ biomarkers, often from a single sample in one visit.